Phase 2 trial shows cross-sectional imaging in advanced metastatic soft tissue sarcomas, indicating potential for combined therapies.
Figure S2. Representative cross-sectional imaging for selected responding patients.
No takes yet. Share an insight, caveat, or question.
Wilky et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: